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Abstract
Background: In clinical practice, patients who are awake often comment that cold surgical skin disinfectant is
unpleasant. This is not only a problem of patients’ experience; heat loss during the disinfection process is a
problem that can result in hypothermia. Evidence for the efficacy of preheated disinfection is scarce.
We tested whether preheated skin disinfectant was non-inferior to room-temperature skin disinfectant on reducing
bacterial colonization during pacemaker implantation.
Methods: This randomized, controlled, non-inferiority trial included 220 patients allocated to skin disinfection with
preheated (36 °C) or room-temperature (20 °C) chlorhexidine solution in 70 % ethanol. Cultures were obtained by
swabbing at 4 time-points; 1) before skin disinfection (skin surface), 2) after skin disinfection (skin surface), 3) after
the incision (subcutaneously in the wound), and 4) before suturing (subcutaneously in the wound).
Results: The absolute difference in growth between patients treated with preheated versus room-temperature skin
disinfectant was zero (90 % CI −0.101 to 0.101; preheated: 30 of 105 [28.6 %] vs. room-temperature: 32 of 112 [28.6 %]).
The pre-specified margin for statistical non-inferiority in the protocol was set at 10 % for the preheated disinfectant.
There were no significant differences between groups regarding SSIs three month postoperatively, which occurred in
0.9 % (1 of 108) treated with preheated and 1.8 % (2 of 112) treated with room-temperature skin disinfectant.
Conclusion: Preheated skin disinfection is non-inferior to room-temperature disinfection in bacterial reduction. We
therefore suggest that preheated skin disinfection become routine in clean surgery.
Trial registration: The study is registered at ClinicalTrials.gov (NCTO2260479).
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Background
Health-care-associated infections are a global concern for
patient safety [1, 2]. With emerging antibiotic resistance, it
is important to find safe preventive measures [3–5].
During clean surgery, such as pacemaker implantation,
surgical site infections (SSIs) are a rare (1–1.25 %) but
serious complication [6–8]. Pathogens isolated from SSIs
are mainly staphylococci, both Staphylococcus aureus and
coagulase-negative staphylococci, and streptococci [1, 4, 9].
Studies have shown that reducing the number of contamin-
ating bacteria can prevent SSIs [10, 11]. Bacteria causing
SSIs originate from the patient or the surgical team [12, 13].
Skin disinfection reduces the number of bacteria,
thereby reducing SSIs [1]. According to the Cochrane
Collaboration, there is insufficient research regarding
the effects of skin disinfection [14]. In clinical practice,
patients comment on the chill they experience during
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skin disinfection prior to surgery. This is not only a prob-
lem of patients’ comfort; heat loss during the disinfection
procedure can cause hypothermia [15]. Hypothermia
causes complications including myocardial events, SSIs,
coagulopathy, and prolonged hospitalization [16, 17]. A
pilot study showed that preheated disinfectant seemed to
be comparable to room-temperature disinfectant in
reducing bacterial growth [18]. To our knowledge
there are no other studies reported that have exam-
ined the effectiveness of preheated skin disinfectant
on bacterial colonization or SSIs.
The primary aim of this study was to test if preheated
(36 °C) skin disinfectant is non-inferior to room-
temperature (20 °C) skin disinfectant regarding skin
colonization. The secondary aim was to investigate
whether gender had an impact on differences in bacterial
colonization in the surgical wound or SSIs among
patients undergoing surgery.
Methods
Study design and participants
This study was a randomized, controlled, non-
inferiority trial that included 220 patients undergoing
pacemaker, implantable cardioverter-defibrillator, or
cardiac resynchronization therapy under local anaes-
thesia. The study was performed at a cardiothoracic
and vascular surgery department in Sweden. Inclusion
criteria were age 18 years or older and ability to read
and understand Swedish. Exclusion criteria were infec-
tion in an existing implanted device. The Regional
Ethical Review Board of Uppsala approved the study
(reference number 2012/255). Written informed con-
sent was obtained.
Intervention and randomization
Patients were included consecutively after arriving in the
operating room (OR). Enrolment to the operation was
done by an external controller who had no knowledge of
the present study. Patients were randomly allocated to
skin disinfectant solution (chlorhexidine 5 mg/mL in
70 % ethanol, Fresenius Kabi AS, Halden, Norway) that
was preheated or at room temperature. Allocation took
place directly after patients provided informed consent.
Patients were stratified by gender and randomly allo-
cated based on a computer-generated randomization list
made by an independent statistician. The patient and
the laboratory technician that performed the analysis
were blinded to the allocation.
Data collection
Patients showered twice with Descutan®, a 4 % chlor-
hexidine soap (Fresenius Kabi AB, Uppsala, Sweden),
prior to surgery. Most patients received elective surgery
and arrived at the hospital on the morning of surgery.
Following standard procedures, intravenously adminis-
tered antibiotic prophylaxis (cloxacillin 2 g) was given in
the ward 15–30 min prior to surgery. The operating
room had an average temperature of 19 °C with upward
displacement ventilation. Sterile disposable surgical
gowns and indicator gloves were worn by the OR team.
Participants underwent skin disinfection during 2 min.
The skin disinfectant was stored at room-temperature
and kept at 20 °C, while the preheated skin disinfectant
was stored in a warming cupboard and kept at 36 °C.
The manufacturer provided a written statement that the
bottles could be stored in a warming cupboard at
temperatures up to 40 °C for 7 days without changing
the compound.
The participants were disinfected from the cheek
down and over the sternum according to routine proce-
dures. Sterile draping was for single use only. Cultures
were obtained at four time-points using a nylon-flocked
swab (ESwab, COPAN Italia S.p.A., via Perotti 10,
Brescia, Italy); 1) before skin disinfection on the skin
surface, 2) after skin disinfection on the skin surface, 3)
directly after the incision (subcutaneously in the wound),
and 4) before closing with sutures (subcutaneously in
the wound). Swabs for cultures were moistened with
saline then rubbed for 15 s on the skin surface (incision
site, approximately 10 mm × 50 mm). Swabs taken in the
wounds were rubbed along the inside of the incision and
along the edges for 15 s with a dry swab. Surgery was
performed by a cardiologist. Cultures were kept cold
until their arrival at the laboratory then analysed
according to a specific study protocol.
The swabs were vortexed for a few seconds and 50 μl
aliquots of the liquor transportation media was subcul-
tured in hematin agar medium 4.3 % (w/v) (Columbia
Blood Agar Base, Acumedia Neogen Corporation,
Lansing, MI, USA) supplemented with 6 % (v/v) choco-
latized defibrinated horse blood and incubated at 36 °C
under aerobic conditions.. Samples were also subcul-
tured on FAA plates (LAB 90 Fastidious Anaerobe Agar
4.6 % [w/v]; LAB M Ltd., Lancashire, UK) supplemented
with 5 % (v/v) defibrinated horse blood and incubated
under anaerobic conditions (10 % H2, 10 % CO2,
80 % N2) at 37 °C for 5 days. After 24 and 48 h of
incubation under aerobic conditions or 5 days under
anaerobic conditions, bacterial growth was determined
quantitatively (colony forming units [cfu]/mL). Culture
diagnostics and species verification were performed
based on characteristic colony morphology, and using
routine diagnostic procedures.
Patient follow-up
After surgery, all patients were followed-up for three
months to detect SSIs, which were defined according
Wistrand et al. Antimicrobial Resistance and Infection Control  (2015) 4:44 Page 2 of 7
to the United States Centers for Disease Control and
Prevention (CDC) criteria for SSI [1].
Statistical analyses
Analyses were performed using SPSS, version 22. The
primary outcome was based on a non-inferiority hypoth-
esis, and the sample size was guided by an earlier study
[18]. A sample size of 102 participants per group pro-
vided 80 % power at a one-sided significance level of 5 %
with an expected proportion of bacterial growth of 0.09
and the maximal allowable difference of 0.10 non-
inferiority limit, which means that a proportional differ-
ence of no more than 0.10 in favour of the pre-heated
disinfectant was accepted as non-inferiority. To cover
potential missing data, the sample size was increased by
16 participants for a total of 220 participants divided
into two groups. Due to a non-inferiority hypothesis, the
absolute difference of the primary outcome was supple-
mented with a two-sided 90 % confidence interval (CI);
otherwise, a regular two-sided 95 % significance level of
5 % was used.
Bacterial counts and other non-normally distributed
variables were analysed with the Mann–Whitney U test
and normally distributed variables with an unpaired t-test.
Categorical variables were evaluated with χ2 -test or
Fisher’s exact test as appropriate.
Results
Recruitment
Between January 2013 and November 2014, 220 pa-
tients receiving pacemakers were enrolled and ran-
domly allocated to receive skin disinfectant that was
preheated (n = 108) or at room-temperature (n = 112).
Patients were followed for three months after surgery
(Fig. 1). Characteristics that are known risk factors
affecting SSIs are; diabetes, eczema, age and others
(Table 1).
Bacterial growth
One hundred and one of 106 (95.3 %) skin cultures
taken before receipt of preheated skin disinfectant
showed growth compared with 108 of 112 (96.4 %) taken
before receipt of room temperature disinfectant. Thirty
of 105 (28.6 %) skin cultures after receipt of preheated
skin disinfectant showed growth compared with 32 of
112 (28.6 %) receiving room-temperature skin
Fig. 1 Flow chart
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disinfectant. The absolute difference in growth was zero
(90 % CI −10.1 to 10.1) (Table 2). Microorganisms iden-
tified before skin disinfection included Propionibacter-
ium acnes, coagulase-negative staphylococci (CoNS),
alpha-haemolytic streptococci, anaerobic diphtheriod
rods, Bacillus species, Micrococcus species, Staphylococ-
cus aureus, anaerobic gram-positive cocci, Proteus spe-
cies, and Rothia mucilaginosa. At subsequent time
points, the amount of different bacteria and the num-
ber of bacteria changed (Fig. 2). The most frequently
identified pathogen after skin disinfection both on the
skin and in the wound was P. acnes followed by
CoNS (Table 3). No significant differences were ob-
served in any of the cultures at the 4 time-points re-
garding growth or median or mean cfu/mL between
the groups (Table 4).
Gender
Cultures showed that males had significantly more
bacteria at the four time-points than females irrespec-
tively of the temperature of the skin disinfectant.
Gender differences at the first time-point appeared in
both the preheated (p = 0.011) and room-temperature
disinfectant groups (p = 0.037). A gender difference
was also seen during the second, third, and fourth
time-point (p ≤ 0.001). Analyses performed on the
overall group or with males and females separately
showed no significant differences regarding disinfec-
tion with preheated or room-temperature disinfectant
(Table 4).
Surgical site infections
There were no significant differences in SSIs three
months postoperatively between patients who received
preheated versus room temperature skin disinfectant; 1
(female) of 108 (0.9 %) vs 2 (1 male and 1 female) of 112
(1.8 %), respectively. At the time of surgery, samples
from females showed growth only before skin disinfec-
tion, whereas the male displayed growth of P. acnes at
all four time-points and CoNS at the first and last time
points. Cultures taken postoperatively, when patients
were diagnosed for SSI, were negative for both female
patients, whereas the cultures from the male patient
were positive for S. aureus, CoNS, P. acnes, and beta-
haemolytic streptococci group G.
Discussion
Bacterial growth
In this study, no significant differences were found
related to the presence of bacteria, confirming that
preheated and room-temperature skin disinfectant have
similar bactericidal effects, as shown in our previous
pilot study [18]. The results clearly show that preheated
Table 1 Patients baseline characteristics and surgical factors
Skin disinfection (chlorhexidine
5 mg/mL in 70 % ethanol)
36 °C 20 °C
Characteristics N = 108 N = 112
Age (years), mean (SD) 72 (11.9) 74 (12.5)
Body mass index (BMI), mean (SD) 27 (4.5) 27 (5.4)
Length of surgery, minutes, median (IQR) 33 (30) 34 (32)
Colony forming units, median (IQR) 1180 (4690) 2080 (4770)
Male, % 55 57
Eczema, % 6 5
Incision site hair shorten, % 31 26
Diabetes, % 14 18
Bacterial skin growth, % 95 96
Type of surgery
Device change, % 45.4 46.4
DDD, % 35.2 36.6
VVI, % 6.5 6.3
ICD, % 1.9 3.6
CRT, % 1.9 1.8
Other, % 9.2 5.4
DDD, dual chamber rate adaptive pacemaker. VVI, single ventricular rate
adaptive pacemaker. ICD, implantable cardioverter-defibrillator. CRT, cardiac
resynchronization therapy. Continuous and dichotomous variables were analysed
using t-test and Mann Whitney U test, no significant differences between groups
Comparison of patients’ characteristics and the surgical factors within each
group (disinfectant at 36 °C or 20 °C, respectively)
Table 2 Bacterial growth at the four time points
Skin disinfection (chlorhexidine
5 mg/mL in 70 % ethanol)
All Men Women
36 °C 20 °C Absolute difference 36 °C 20 °C 36 °C 20 °C
n = 106 n = 112 (90 % CI) n = 62 n = 62 n = 44 n = 50
Before skin disinfection 95.3 96.4 100 100 88.6 92
After skin disinfectiona 28.6 28.6 0 (−0.101 to 0.101) 40.3 43.5 11.6 10
After incision (wound) 24.5 30.4 −0.059 (−0,158 to 0.040) 40.3 45.2 2.3 12
Before wound closure (wound) 53.8 62.5 −0.087 (−0,197 to 0,023) 74.2 82.3 25 38
Proportion of swabs from patients that showed any bacterial growth at the various time points. Data are shown as percentages and absolute difference with
confidence intervals (CI)
aPrimary outcome
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Fig. 2 Bacterial growth before and after skin disinfectant. Bacterial growth before and after treatment with skin disinfectant (chlorhexidine
5 mg/mL in 70 % ethanol) at the four time points. The median is identified by a line inside the box. The length of the box is the interquartile range (IQR),
and whiskers are min and max if no outliers are present. Outliers of more than 1.5 IQR’s are labeled as (o) and outliers of more than
three IQR are labelled as (*)
Table 3 Species of bacteria identified
Culture 1 Culture 2 Culture 3 Culture 4
Microorganism 36 °C 20 °C 36 °C 20 °C 36 °C 20 °C 36 °C 20 °C
n = 106 n = 112 n = 105 n = 112 n = 106 n = 112 n = 106 n = 112
P. acnes 83 86 25 25 22 29 47 52
CoNS 83 90 2 4 2 6 23 29
S. aureus 2 2 1 1 - - - -
Alpha-haemolytic 9 9 - - - - - 1
Anaerobic diphtheriod rods 5 3 - 1 1 1 1 1
Bacillus species 2 1 - - - - - -
Micrococci 4 - - - - - - -
Anaerobic gram-positive cocci 1 2 - 1 1 - - 3
Proteus sp. 2 - - - - - 1 -
R. mucilaginosa - 1 - - - - - -
No significant differences between study groups for any microorganism at any time point. Chi-2 test were used as statistical method
Bacterial species identified from swabs taken from patients who received preheated and room-temperature skin disinfectant (chlorhexidine 5 mg/mL in 70 % ethanol)
with growth in cultures taken perioperatively; 1) before skin disinfection, 2) after skin disinfection, 3) after incision (wound), and 4) before skin closure (wound)
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or room temperature skin disinfectant reduce the num-
ber of bacteria on the skin and prevent SSIs equally well.
The most frequently identified bacteria in the wound
after disinfection was P. acnes, which also inhabits
deeper layers of the skin [19, 20]. A possible explan-
ation is that when the incision is made, deeper
layers of the skin are exposed and P. acnes relocate
into the wound [20]. P. acnes can be a causative fac-
tor of SSIs [20–23].
Gender
Earlier studies have shown that the amount of bac-
teria differs between males and females and this study
supports that finding [12, 24]. The effectiveness of
preheated or room-temperature skin disinfectant was
equivalent.
Surgical site infections
The male patient who experienced SSI showed growth in
cultures taken at all four time-points. Two other species
of bacteria, S. aureus and beta-haemolytic streptococci
group G, were also found when the SSI was diagnosed.
These species were not present at the time of surgery.
Cultures taken postoperatively to determine the causative
pathogens were negative in the female patients with SSIs.
According to the criteria, SSI could be diagnosed as
purulent drainage, fever, tenderness, and usually a
positive culture or diagnosed as SSI by the attending
physician [1]. The reason these cultures did not show
any growth could possibly be due to an ability of the
bacteria to protect themselves with biofilm [19], but
also because P. acnes has a slow-growing nature [23].
Limitations
There are limitations to this study. First, this study had a
power problem related to the population size because
the power calculation was made based on 10 % growth,
whereas in the present study the patients showed 28.6 %
bacterial growth after skin disinfection. Secondly, this
study was designed as a non-inferiority trial to detect
differences in bacterial contamination, not to detect
differences in SSIs.
In conclusion, recommendations aimed at preventing
SSIs should be evidence based [25]. The assumption that
preheated skin disinfection is non-inferior to room-
temperature disinfectant in bacterial reduction appears to
be correct. We therefore suggest that preheated skin disin-
fection can be used routinely prior to clean surgery. Add-
itional studies involving other types of surgery, including
those affecting other body sites and levels of complexity
and length, are warranted.
Competing interests
B. Söderquist has been a consultant for Pfizer and Janssen-Cilag. Otherwise,
the authors have no financial, personal, or other relationship that could be
viewed as presenting a potential conflict of interests.
Authors’ contributions
All named authors have seen and agreed to the submitted version of the
paper as well as those included inthe acknowledgements section. CW was
the main author. BS and UN supervised the writing and was also involved in
the planing of the manuscript. BS was responsible for the protocol and the
departement of microbiology. AM aided with statistics. BS has been a
consultant for Pfizer and Janssen-Cilag. All authors read and approved the
final manuscript.
Acknowledgements
We wish to express our gratitude to all who were involved in the operating
department and the department of laboratory medicine, Clinical
Microbiology. We thank Tommy Andersson, Peter Lindell, who performed all
surgery, and Bengt Hellmark, who contributed everything that was needed
at the department of laboratory medicine.
Role of the funding source
This study was funded by Örebro County Council Research Committee,
Örebro, Sweden and Örebro University.
Author details
1Faculty of Medicine and Health, School of Health Sciences, Örebro, SE 701 82,
Sweden. 2Faculty of Medicine and Health, School of Medical Sciences, Örebro, SE 701
82, Sweden. 3Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health,
Örebro University, Örebro, SE 701 82, Sweden. 4Department of Cardiothoracic surgery
and Vascular surgery, University hospital in Örebro, Grevrosengatan, 701 85 Örebro,
Sweden.
Table 4 Mean bacterial growth
Mean cfu/mL
Skin disinfection (Chlorhexine 5 mg/mL in 70 % ethanol) All Men Women
36 °C 20 °C 36 °C 20 °C 36 °C 20 °C
n = 106 n = 112 n = 62 n = 62 n = 44 n = 50
Before skin disinfection 2388 2687 3516 3734 825 1389
After skin disinfection 298 199 500 277 5 85
After incision (wound) 347 383 592 576 1 144
Before wound closure (wound) 973 1004 1570 1615 131 258
No statistically significant differences between preheated and room-temperature skin disinfectant within study groups at any time point evaluated for all patients
as well as for men and women separately. Mann Whitney U test used as statistical method. Cultures showed that male had significantly more bacteria at all four
time-points than females irrespectively of temperature. Mann Whitney U test used as statistical method
Bacterial growth, represented as mean cfu/mL, observed in cultures from patients who received preheated skin disinfectant compared with room-temperature skin
disinfectant at the four perioperative time-points. Data were combined for the overall group and for males and females separately
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